MW
VRTX icon

MBL Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

MBL Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Sell
557
-27
-5% -$12.6K 0.02% 284
2025
Q4 		$265K Buy
+584
New +$252K 0.02% 252
2025
Q3 		– Sell
-542
Closed -$241K – 260
2025
Q2 		$241K Sell
542
-11
-2% -$5.07K 0.02% 210
2025
Q1 		$268K Sell
553
-72
-12% -$33.6K 0.03% 188
2024
Q4 		$252K Sell
625
-79
-11% -$36.6K 0.03% 193
2024
Q3 		$327K Sell
704
-79
-10% -$37.9K 0.04% 158
2024
Q2 		$367K Sell
783
-105
-12% -$45.6K 0.04% 147
2024
Q1 		$371K Buy
+888
New +$375K 0.04% 142

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return